Drug Trial Radar · NCT05139810
OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)
Last checked: Nov 20, 2026Latest source record: Mar 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
91
Actual
Start
Dec 3, 2021
Primary completion
Nov 9, 2023
Study completion Nov 9, 2023
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Dec 1, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to evaluate the safety and efficacy of donidalorsen in participants with HAE and effect of donidalorsen on the quality and pattern of HAE attacks and their impact on quality of life (QoL).
Conditions
- Hereditary Angioedema
Interventions
DonidalorsenDrug
Donidalorsen was administered by SC injection.
PlaceboDrug
Donidalorsen-matching placebo was administered by SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time-Normalized Investigator-Confirmed (IC) HAE Attack Rate (Per Month) From Week 1 to Week 25Time frame: Week 1 to Week 25
Locations
51 sites in 14 countries. Site status is shown where the registry gives one.
Ionis Investigative Site
Scottsdale, Arizona
Ionis Investigative Site
San Diego, California
Ionis Investigative Site
Santa Monica, California
Ionis Investigative Site
Walnut Creek, California
Ionis Investigative Site
Colorado Springs, Colorado
Ionis Investigative Site
Tampa, Florida
Ionis Investigative Site
Kansas City, Kansas
Ionis Investigative Site
Boston, Massachusetts
Ionis Investigative Site
Ann Arbor, Michigan
Ionis Investigative Site
St Louis, Missouri
Ionis Investigative Site
Columbus, Ohio
Ionis Investigative Site
Toledo, Ohio
Ionis Investigative Site
Hershey, Pennsylvania
Ionis Investigative Site
Dallas, Texas
Ionis Investigative Site
Murray, Utah
Ionis Investigative Site
Brussels, Belgium
Ionis Investigative Site
Brussels, Belgium
Ionis Investigative Site
Edegem, Belgium
Ionis Investigative Site
Sofia, Bulgaria
Ionis Investigative Site
Sofia, Bulgaria
Ionis Investigative Site
Edmonton, Canada
Ionis Investigative Site
Ottawa, Ontario, Canada
Ionis Investigative Site
Odense, Denmark
Ionis Investigative Site
La Tronche, France
Ionis Investigative Site
Marseille, France
Ionis Investigative Site
Paris, France
Ionis Investigative Site
Berlin, Germany
Ionis Investigative Site
Frankfurt, Germany
Ionis Investigative Site
Munich, Germany
Ionis Investigative Site
Ashkelon, Israel
Ionis Investigative Site
Haifa, Israel
Ionis Investigative Site
Tel Aviv, Israel
Ionis Investigative Site
Catania, Italy
Ionis Investigative Site
Milan, Italy
Ionis Investigative Site
Naples, Italy
Ionis Investigative Site
Padova, Italy
Ionis Investigative Site
Palermo, Italy
Ionis Investigative Site
Amsterdam, Netherlands
Ionis Investigative Site
Groningen, Netherlands
Ionis Investigative Site
Krakow, Poland
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.